Join us Sept. 14-16 in Miami to connect with top publishing leaders
Digiday Podcast at Cannes Lions: Why Hilton CMO Mark Weinstein says the ‘hot air’ AI hype cycle isn’t over yet
Digiday covers the latest from marketing and media at the annual Cannes Lions International Festival of Creativity. More from the series →
Subscribe: Apple Podcasts • Spotify
Bonjour from day one of the annual Cannes Lions International Festival of Creativity and the kick-off of the Digiday Cannes podcast. Ahead of this year’s rosé-induced festivities, Hilton CMO Mark Weinstein, a Cannes Lions veteran attendee, joins us for the first episode of Digiday’s week-long podcast series.
Last year’s generative artificial intelligence hype cycle hasn’t quite fizzled out yet It’s expected not only to show up this year, says Weinstein, but drown out other conversations. No doubt, marketers have found uses for gen AI beyond social copy and internal content creation, but it’s yet to be said if AI will reach an inflection point for brand at this year’s Lions.
“Unfortunately, a lot of the conversation will be just blustering and hot air,” Weinstein said. “We’re not yet at a point where any of us know, including the people building the capabilities by the way, where this ends.”
Tune in to hear how Hilton is using AI internally and how Weinstein says the industry should be talking about AI at this year’s Cannes Lions on the Digiday Podcast at Cannes.
And Make sure to tune in tomorrow for the next Digiday podcast at Cannes.
More in Marketing
Future of Marketing Briefing: The public ad tech era is over
Gone are the days when investors got themselves in a tizzy over ad networks, demand-side platforms and supply-side platforms on their own merits.
By the numbers: Wall Street’s tough assessment of ad tech
Big Tech continues to dominate digital growth, triggering a Wall Street exodus, but are returns imminent?
CMOs are struggling to link AI visibility with sales
Brands are spending on tools that rate their visibility within LLM responses and AI search, but proving the commercial impact of GEO remedies isn’t easy.